Introduction {#s1}
============

Hypopharyngeal cancer accounts for 2--6% of head neck cancers. [@pone.0056613-Ligier1], [@pone.0056613-Takes1] The prognosis of patients with cancer of the hypopharynx can be poor despite aggressive combined modality treatment. [@pone.0056613-Pfister1] Traditionally, laryngopharyngectomy with reconstruction of the pharynx has been the preferred initial treatment modality for hypopharyngeal cancers. In an attempt to limit the morbidity of surgical therapy, nonsurgical treatments have gained popularity. [@pone.0056613-Takes1] While for selected patients with early T classification hypopharyngeal cancer, transoral laser microsurgery in combination with neck dissection and postoperative radiotherapy shows results comparable to those of open surgical procedures and radiotherapy, morbidity and complication rates tend to be lower. [@pone.0056613-Suarez1] For patients with a T4a classification (tumor invasion of thyroid/cricoid cartilage, hyoid bone, thyroid gland or the central compartment of soft tissue), surgery plus neck dissection followed by adjuvant chemotherapy/radiotherapy or radiotherapy has been preferred in accordance to the NCCN guidelines. [@pone.0056613-Pfister1]

When primary surgery is the selected management path for resectable hypopharyngeal cancer cases, postoperative chemotherapy/radiotherapy is recommended (level I evidence) for the adverse pathologic features of extracapsular nodal spread and/or a positive mucosal margin. [@pone.0056613-Pfister1], [@pone.0056613-Bernier1] For other risk features, clinical judgment should be used when deciding to use radiotherapy alone or when considering including chemotherapy with radiotherapy. A better postoperative staging system for hypopharyngeal cancer would be helpful in selecting suitable patients for more intensified postoperative therapy and in the design of clinical trials. The lymph node ratio (LNR), defined as the number of involved nodes divided by the number of lymph nodes examined, was found to improve prognostic information in breast cancer, gastric cancer, colorectal cancer, melanoma and others. [@pone.0056613-Spillane1], [@pone.0056613-VinhHung1], [@pone.0056613-Wang1], [@pone.0056613-Ceelen1], [@pone.0056613-Deng1], [@pone.0056613-Gao1], [@pone.0056613-Song1] Approximately 60% to 80% of patients with hypopharyngeal cancer have locally advanced disease with spread to regional nodes at diagnosis. [@pone.0056613-Kotwall1] However, there have been no previous studies on the impact of the LNR on predicting the prognosis of hypopharyngeal cancer.

In the current study, the prognostic role of LNR was analyzed in SEER (Surveillance, Epidemiology and End Results)-registered hypopharyngeal cancer patients with lymph node metastasis. In addition, the cutoff points for the LNR in defining patients as high, medium or low risk groups were identified. The predictive accuracy for survival of the categorical LNR was also compared with the pN classification of hypopharyngeal cancer.

Materials and Methods {#s2}
=====================

Patients {#s2a}
--------

The SEER Cancer Statistics Review (<http://seer.cancer.gov/>), a report on the most recent cancer incidence, mortality, survival, prevalence and lifetime risk statistics, is published annually by the Data Analysis and Interpretation Branch of the National Cancer Institute, MD, USA. [@pone.0056613-Surveillance1] SEER collects and publishes these statistics from population-based registries covering 26% of the US population. The 17 SEER registries routinely collect data on patient demographics, primary tumor site, tumor morphology, extent of disease, first course of treatment and active follow-up for vital status. [@pone.0056613-Surveillance1] The SEER set has been widely used for the analysis of LNR staging of breast, colon, gastric and other cancers. [@pone.0056613-Gao1], [@pone.0056613-VinhHung2], [@pone.0056613-Wang2].

Cases of hypopharyngeal carcinoma from 1988 to 2008 were extracted from the SEER database (SEER\*Stat 7.0.5) according to the Site Recode classifications. The data were standardized according to the schema of the International Classification of Disease for Oncology. Cancers were limited to the hypopharynx, which were defined as the pyriform sinus (C12.9), postcricoid region (C13.0), hypopharyngeal aryepiglottic fold (C13.1), posterior wall of the hypopharynx (C13.2), overlapping lesion of the hypopharynx (C13.8) and hypopharynx, NOS (C13.9). Histology was limited to squamous cell carcinoma (histology recode - broad groupings 8050--8090). Only hypopharyngeal carcinomas as a single primary tumor or the first diagnosed cancer type of two or more primary tumors were included in current study due to the available information for cause specific survival analysis in SEER database. The LNR was calculated as the number of positive regional nodes (1988+) divided by the number of regional nodes examined (1988+). The cases with disconcordant N classification information and the number of positive regional lymph nodes recorded in SEER database were rejected (N = 116). Finally, a total of 1152 cases of hypopharyngeal carcinoma were collected as the analysis set, and among them 916 cases had pathological lymph node involvement (pN+). This study was based on public use de-identified data from the U.S. SEER database and did not include interaction with human subjects or use personal identifying information. The study did not require informed consent and was approved by the Review Board of Fudan Univesity Shanghai Cancer Center, Shanghai, China. The authors, however, obtained Limited-Use Data Agreements from SEER.

Statistical Analysis {#s2b}
--------------------

The categorical and continuous variables of hypopharyngeal cancer cases were retrieved from the SEER database and rechecked. TNM staging information was restaged according to the 2010 American Joint Committee on Cancer (AJCC) staging system, and cases with insufficient classification were defined as X. The CSS (SEER cause-specific survival, <http://seer.cancer.gov/causespecific/>) was a net survival measure representing survival of a specified cause of death in the absence of other causes of death. The 'SEER cause-specific death classification' variable is used to obtain cancer-specific survival probability for a given cohort of cancer patients. Deaths attributed to the cancer of interest are treated as events and deaths from other causes are treated as censored observation. [@pone.0056613-Surveillance1] The overall survival (OS) was calculated based on the Vital status recode. [@pone.0056613-Surveillance1].

The analysis was carried out in three stages. First, we evaluated the prognostic value of LNR as a continuous variable, adjusting for other covariates associated with CSS in 916 pN+ hypopharyngeal cancer cases. In the second stage, we proceeded to determine the most appropriate cutoff points for categorizing the LNR into high, medium and low risk groups, and compared the predictive accuracy for survival between the categorical LNR and the continuous LNR. The fist pair of cutoff points was identified by means of tertiles of continuous LNR. The second pair of cutoff points were analyzed using the X-tile program (<http://www.tissuearray.org/rimmlab/>), which identified the cutoff with the minimum *P* values from log-rank χ^2^ statistics for the categorical LNR in terms of survival. [@pone.0056613-Wang1], [@pone.0056613-Camp1] The third pair of cutoff points were calculated according to Akaike information criterion (AIC) selection for the multivariate Cox regression model. [@pone.0056613-VinhHung1] Using R software with the MASS, Boot and Survival package, the possible pair of cutoff points with the maximum likelihood associated with the multivariate Cox regression model, which ranged from 0.05 to 0.95 at intervals of 0.05, was identified as the third pair of cutoff points. Patients with hypopharyngeal cancer (N = 1152) were classified into four categories (R0-3) according to the identified LNR cutoff points. The prognostic significance of categorical LNR (R classification) was compared with the pN classification.

Survival curves were plotted and survival rates were calculated using the Kaplan-Meier method. Statistical comparisons of different factors related to mortality were undertaken using the Log-rank χ^2^ test. In multivariate analysis, forward stepwise regression analysis was carried out using a Cox proportional hazards model. Harrell's concordance index (C-index) and AIC values related to the Cox regression model were analyzed to compare the predictive ability of the continuous LNR and categorical LNR for the identification of the optimal cutoff points for the LNR, and the R and pN classifications. [@pone.0056613-Bradburn1], [@pone.0056613-Harrell1] A higher C-index value and a lower AIC value indicated a more desirable model for predicting outcome. A *P* value of 0.05 was considered statistically significant. All statistical analyses were carried out using SPSS software version 17.0 (SPSS Inc., Chicago, IL) and R2.14.0 software with packages. [@pone.0056613-The1].

Results {#s3}
=======

Lymph Node Ratio as a Prognostic Factor for Survival in Hypopharyngeal Cancer {#s3a}
-----------------------------------------------------------------------------

The clinical characteristics of the 916 SEER patients with pN+ hypopharyngeal cancer are shown in [Table 1](#pone-0056613-t001){ref-type="table"}. The median age of patients was 61 years (range 35--93 years). The median number of lymph nodes examined, positive lymph nodes and lymph node ratio were 25 (range 1--90), 2 (range 1--90) and 0.14 (range 0.01--1.00), respectively. The median follow-up time was 23 months (range, 0--238 months). There were 495 cases with cancer caused death, 181 cases with non-cancer caused death, 238 alive cases and 2 cases lost during follow-up at the end of follow-up. Kaplan-Meier estimates of 1-, 3-, 5- and 10-year CSS were 76.3%, 51.0%, 42.3% and 33.6%, respectively, and estimates of 1-, 3-, 5- and 10-year OS were 76.3%, 43.9%, 30.9% and 18.7%, respectively. The case number and 5-year CSS of patients diagnosed at 1988--1994, 1995--2001, 2002--2008 were 282, 298, 336 and 42.1%, 43.1%, 41.4%, respectively. There was no changes of the survival for pN+ hypopharyngeal cancer cases diagnosed at different period (Log-rank χ^2^ 0.156, *P* = 0.925). The univariate analysis showed that race, primary site, radiation sequence, cancer directed surgery, T classification, N classification and M classification were all associated with CSS in 916 pN+ hypopharyngeal cancer cases. When these factors were assessed using multivariate Cox regression analysis, we found that race, primary site, radiation sequence, T classification, N classification, M classification, the number of regional lymph nodes examined, continuous LNR and age were all independent variables ([Table 2](#pone-0056613-t002){ref-type="table"}).

10.1371/journal.pone.0056613.t001

###### Clinicopathological characteristics and Kaplan-Meier cause specific survival (CSS) analysis of SEER hypopharyngeal cancer cases with pathological lymph node involvement.

![](pone.0056613.t001){#pone-0056613-t001-1}

  Variables                  No.   5-year CSS   Log-rank χ^2^   *P* value
  ------------------------- ----- ------------ --------------- -----------
  Race                                             29.840        \<0.001
  White                      696     46.2%                     
  Black                      155     26.7%                     
  Other                      65      37.5%                     
  Gender                                            0.303         0.582
  Male                       750     41.7%                     
  Female                     166     44.8%                     
  Year of diagnosis                                 0.156         0.925
  1988--1994                 282     42.1%                     
  1995--2001                 298     43.1%                     
  2002--2008                 336     41.4%                     
  Primary site                                     17.637         0.003
  Pyriform sinus             664     43.2%                     
  Postcricoid region         20      28.7%                     
  Aryepiglottic fold         25      63.4%                     
  Posterior wall             36      42.0%                     
  Overlapping lesion         24      13.8%                     
  Hypopharynx, NOS           147     42.1%                     
  Histological grade                                3.230         0.520
  I                          28      36.5%                     
  II                         370     44.6%                     
  III                        406     40.8%                     
  IV                         16        0                       
  Unknown                    96      39.9%                     
  Surgery of primary site                           1.317         0.725
  None                       216     40.0%                     
  Local excision             92      48.4%                     
  Pharyngectomy              595     42.4%                     
  Unknown                    13        0                       
  Radiation sequence                               25.588        \<0.001
  No radiation               226     34.5%                     
  Pre-operative              50      35.1%                     
  Post-operative             620     46.1%                     
  Other                      20        0                       
  Cancer directed surgery                           7.519         0.006
  Yes                        747     43.2%                     
  Other                      169     38.9%                     
  T stage                                          38.547        \<0.001
  T1                         81      65.9%                     
  T2                         152     56.1%                     
  T3                         144     39.6%                     
  T4                         376     33.2%                     
  Tx                         163     41.8%                     
  N stage                                          15.483        \<0.001
  N1                         194     51.4%                     
  N2                         653     41.5%                     
  N3                         69      23.0%                     
  M stage                                          46.848        \<0.001
  M0                         871     43.8%                     
  M1                         31       5.4%                     
  Mx                         14      24.2%                     

10.1371/journal.pone.0056613.t002

###### Multivariate analysis of the LNR and covariates associated with SEER cancer cause-specific survival of hypopharyngeal cancer cases with lymph node metastasis.
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  Variables                                             HR (95% CI)       *P* value
  ------------------------------------------------ --------------------- -----------
  Race (White as reference)                                              
  Black                                             1.678(1.334--2.112)    \<0.001
  Other                                             1.392(0.999--1.940)     0.051
  Primary site (Pyriform sinus as reference)                             
  Postcricoid region                                1.088(0.619--1.911)     0.769
  Aryepiglottic fold                                0.664(0.338--1.305)     0.235
  Posterior wall                                    2.327(1.459--3.711)    \<0.001
  Overlapping lesion                                2.140(1.327--3.453)     0.002
  Hypopharynx, NOS                                  1.206(0.935--1.555)     0.149
  Radiation sequence (no radiation as reference)                         
  Pre-operative                                     0.976(0.642--1.482)     0.908
  Post-operative                                    0.643(0.512--0.807)    \<0.001
  Other                                             1.060(0.580--1.936)     0.850
  T classification (T1 as reference)                                     
  T2                                                1.441(0.906--2.292)     0.122
  T3                                                2.504(1.597--3.925)    \<0.001
  T4                                                2.965(1.954--4.497)    \<0.001
  Tx                                                1.671(1.055--2.648)     0.029
  N classification (N1 as reference)                                     
  N2                                                1.352(1.064--1.717)     0.014
  N3                                                2.224(1.544--3.202)    \<0.001
  M classification (M0 as reference)                                     
  M1                                                4.195(2.679--6.569)    \<0.001
  MX                                                1.289(0.636--2.613)     0.482
  No. of regional lymph node examined               1.009(1.003--1.014)     0.002
  LNR as continuous variable                        2.415(1.707--3.416)    \<0.001
  Age                                               1.017(1.007--3.416)    \<0.001

Identification of LNR Cutoff Points {#s3b}
-----------------------------------

The complexity of the underlying computations for obtaining the hazard ratios for the continuous LNR ensures that the immediately readable hazard ratios for the categorized LNR are preferred in daily clinical practice. To stratify the patients with lymph node metastasis as high, medium and low risk groups associated with CSS, the upper and lower tertiles of continuous LNR that corresponded to 0.09 and 0.27 were defined as the first pair of cutoff points. The X-tile, which can control the inflated type I error problem and minimize the loss of information due to multiple testing through cross-validation, identified 0.08/0.33 as the second pair of cutoff points. [@pone.0056613-Wang1], [@pone.0056613-Camp1] After recomputing the likelihood associated with all pairs of LNR cutoffs (dividing patients into three risk groups) using the multivariate regression model ([Table 2](#pone-0056613-t002){ref-type="table"}), 0.05/0.30 was identified as the third pair of cutoff points with the maximum likelihood associated with the Cox regression model. The SEER cases with lymph node metastasis were stratified as high, medium and low risk groups according to the three pairs of cutoff points identified above. The case numbers, the 5-year CSS and 5-year OS of the different risk groups were summarized in [Table 3](#pone-0056613-t003){ref-type="table"}. To compare the predictive ability of the categorical LNR and the continuous LNR, the C-index and AIC value of the Cox regression model ([Table 2](#pone-0056613-t002){ref-type="table"}) with substitution of the continuous LNR with the categorical LNR were calculated. As listed in [Table 3](#pone-0056613-t003){ref-type="table"}, all three pairs of the categorical LNRs showed superior predictive ability to that of the continuous LNR, with the lower AIC value and higher C-index value associated with the Cox regression model. For the sake of convenience in clinical interpretation and application, the cutoff points 0.05/0.30 with the lowest AIC values were used for further analysis.

10.1371/journal.pone.0056613.t003

###### Univariate and multivariate analysis of the categorical and continuous LNR with cause-specific survival (CSS) and overall survival (OS) of SEER hypopharyngeal cancer patients with lymph node metastasis.
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  LNR classification     No.   5-y CSS(%)   Log-rank χ^2^ [†](#nt101){ref-type="table-fn"}   HR (95% CI) [‡](#nt102){ref-type="table-fn"}   C-index[‡](#nt102){ref-type="table-fn"}   AIC[‡](#nt102){ref-type="table-fn"}   5-y OS(%)   Log-rank χ^2^ [\#](#nt103){ref-type="table-fn"}   HR (95% CIs) [\*](#nt104){ref-type="table-fn"}   C-index[\*](#nt104){ref-type="table-fn"}   AIC[\*](#nt104){ref-type="table-fn"}
  --------------------- ----- ------------ ------------------------------------------------ ---------------------------------------------- ----------------------------------------- ------------------------------------- ----------- ------------------------------------------------- ------------------------------------------------ ------------------------------------------ --------------------------------------
  Continuous LNR                                                                                         2.415(1.707--3.416)                                 0.688                                  5946.70                                                                                            2.005(1.483--2.712)                                  0.668                                   8001.08
  Cutpoints 0.09/0.27                                           39.326                                                                                       0.695                                  5943.40                                                 28.887                                                                                          0.672                                   7997.18
  R1∶0--0.09             330      51.6                                                                        Reference                                                                                                       38.9                                                                          Reference                                                                
  R2∶0.09--0.27          285      40.9                                                                   1.451(1.131--1.861)                                                                                                  30.0                                                                     1.328(1.076--1.639)                                                           
  R3: \>0.27             301      32.6                                                                   2.150(1.631--2.845)                                                                                                  22.4                                                                     1.855(1.463--2.353)                                                           
  Cutpoints 0.08/0.33                                           35.427                                                                                       0.698                                  5937.27                                                 37.160                                                                                          0.675                                   7988.71
  R1∶0--0.08             301      52.0                                                                        Reference                                                                                                       39.5                                                                          Reference                                                                
  R2∶0.08--0.33          357      41.9                                                                   1.523(1.190--1.948)                                                                                                  30.1                                                                     1.343(1.090--1.653)                                                           
  R3: \>0.33             258      30.3                                                                   2.488(1.848--3.350)                                                                                                  21.3                                                                     2.160(1.672--2.790)                                                           
  Cutpoints 0.05/0.30                                           33.768                                                                                       0.697                                  5934.87                                                 33.894                                                                                          0.674                                   7988.71
  R1∶0--0.05             177      55.6                                                                        Reference                                                                                                       43.1                                                                          Reference                                                                
  R2∶0.05--0.30          458      43.6                                                                   1.686(1.262--2.252)                                                                                                  31.6                                                                     1.461(1.151--1.856)                                                           
  R3: \>0.30             281      30.7                                                                   2.822(2.011--3.959)                                                                                                  21.3                                                                     2.301(1.729--3.062)                                                           

The *P* value for Log-rank χ^2^ tests of cause specific survival was less than 0.001.

Being calculated using the multivariates Cox regression model for cause specific survival with either continuous or categorical LNR and variates listed at [Table 2](#pone-0056613-t002){ref-type="table"} as covariates.

The *P* value for Log-rank χ^2^ tests of overall survival was less than 0.001.

Being calculated using the multivariates Cox regression model for overall survival with either continuous or categorical LNR and variates listed at [Table 2](#pone-0056613-t002){ref-type="table"} as covariates.

Superiority of the R Classification Over the pN Classification in the Prediction of Survival {#s3c}
--------------------------------------------------------------------------------------------

Since the N classification and LNR are both lymph node staging system, the 1152 SEER cases of hypopharyngeal carcinoma were classified as the four risk groups, R0 (LNR, 0), R1 (LNR, 0--0.05), R2 (LNR, 0.05--0.30), R3 (LNR, \>0.30) and defined as the R classification to compare with traditional N classification. Univariate analysis ([Table 4](#pone-0056613-t004){ref-type="table"}) and multivariate Cox regression analysis ([Table 5](#pone-0056613-t005){ref-type="table"}) indicated that race, primary site, T classification, N classification, M classification, radiation sequence, cancer directed surgery and age had a significant association with CSS. When substituting the N classification with the R classification, the Cox regression model of CSS for the R classification showed a lower AIC value and higher C-index value, which suggested that Cox regression model with R classification had better predictive ability ([Table 5](#pone-0056613-t005){ref-type="table"}). The Cox regression model for the R classification was also superior to the N classification in predicting OS ([Table 5](#pone-0056613-t005){ref-type="table"}). [Table 5](#pone-0056613-t005){ref-type="table"} and [Figure 1](#pone-0056613-g001){ref-type="fig"} show the univariate Kaplan-Meier CSS and OS estimates according to risk groups, defined using the pN ([Fig. 1A and C](#pone-0056613-g001){ref-type="fig"}) or R classification ([Fig. 1B and D](#pone-0056613-g001){ref-type="fig"}). As shown at [Figure 1](#pone-0056613-g001){ref-type="fig"}, for the 5-year CSS or OS, both the N and R classifications showed good discriminatory ability among each group. For the 10-year CSS and OS, the survival curves for N1 and N2 crossed at 35% and 19%. The 15-year CSS and OS survival curves for N1, N2 and N3 classifications converged at 23% and 10%, respectively ([Table 5](#pone-0056613-t005){ref-type="table"}). In comparison, the 10-year CSS and OS curves for the R1-3 classification were clearly separated even with a follow-up time exceeding 15 years. For the R classification, similar survival curves were obtained for the R1 (lower LNR) and R0 (no lymph node metastasis) groups ([Fig. 1B and D](#pone-0056613-g001){ref-type="fig"}), and the adjusted hazard ratio (95% CIs) of the Cox regression model for the R1 group was 1.134 (0.901--1.439) for CSS and 1.072 (0.850--1.352) for OS, when using R0 as the reference group ([Table 5](#pone-0056613-t005){ref-type="table"}).

![Kaplan-Meier survival estimates for different patient groups.\
SEER cause-specific survival of the hypopharyngeal cancer cases with different pN classification (A) and R classification (B). Overall survival for different pN classifications (C) and R classifications (D). The SEER cause-specific survival (E) and overall survival (F) differences observed in N2-3/R2-3 group and other hypopharyngeal cancer patients with and without postoperative radiotherapy.](pone.0056613.g001){#pone-0056613-g001}

10.1371/journal.pone.0056613.t004

###### Univariate analysis of clinicopathological variables associated with SEER cause-specific survival (CSS) and overall survival (OS) of hypopharyngeal cancer patients (n = 1152).
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  Patients' variables        No.    5-y CSS (%)   Log-rank χ^2^   *P* value   5-y OS(%)   Log-rank χ^2^   *P* value
  ------------------------- ------ ------------- --------------- ----------- ----------- --------------- -----------
  Race                                               28.206        \<0.001                   26.402        \<0.001
  White                      872       50.5                                     37.1                     
  Black                      198       33.8                                     23.9                     
  Other                       82       42.1                                     33.9                     
  Primary site                                       18.132         0.003                     9.588         0.088
  Pyriform sinus             829       48.0                                     34.8                     
  Postcricoid region          24       33.4                                     23.2                     
  Aryepiglottic fold          38       69.6                                     52.0                     
  Posterior wall              48       39.9                                     27.6                     
  Overlapping lesion          27       21.6                                     18.3                     
  Hypopharynx, NOS           186       48.2                                     34.1                     
  T classification                                   37.299        \<0.001                   36.991        \<0.001
  T1                          93       68.7                                     53.9                     
  T2                         203       61.5                                     47.0                     
  T3                         181       43.0                                     32.5                     
  T4                         484       39.5                                     28.1                     
  Tx                         191       44.5                                     30.4                     
  N classification                                   41.026        \<0.001                   22.437        \<0.001
  N0                         236       64.7                                     47.3                     
  N1                         194       51.4                                     38.8                     
  N2                         653       41.5                                     29.8                     
  N3                          69       23.0                                     15.8                     
  M classification                                   49.844        \<0.001                   46.822        \<0.001
  M0                         1099      48.7                                     35.5                     
  M1                          36       12.3                                      7.0                     
  Mx                          17       30.5                                     20.2                     
  Radiation sequence                                 24.501        \<0.001                   26.596        \<0.001
  No radiation               292       40.4                                     28.3                     
  Pre-operative               61       40.3                                     35.8                     
  Post-operative             776       50.8                                     36.9                     
  Other                       23       35.9                                     21.7                     
  Cancer directed surgery                            18.421        \<0.001                   14.241        \<0.001
  Yes                        970       48.6                                     35.4                     
  Other                      182       38.5                                     28.8                     

10.1371/journal.pone.0056613.t005

###### Different staging systems for SEER cause-specific survival (CSS) and overall survival (OS) of SEER patients with hypopharyngeal cancer.
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  Staging system      No.   5/10/15-y CSS(%)   log-rank χ^2^ [†](#nt105){ref-type="table-fn"}   HR (95% CI) [‡](#nt106){ref-type="table-fn"}   C-index[‡](#nt106){ref-type="table-fn"}   AIC[‡](#nt106){ref-type="table-fn"}   5/10/15-y OS(%)   log-rank χ^2\#^   HR (95% CIs) [\*](#nt108){ref-type="table-fn"}   C-index[\*](#nt108){ref-type="table-fn"}   AIC[\*](#nt108){ref-type="table-fn"}
  ------------------ ----- ------------------ ------------------------------------------------ ---------------------------------------------- ----------------------------------------- ------------------------------------- ----------------- ----------------- ------------------------------------------------ ------------------------------------------ --------------------------------------
  N classification                                                 41.026                                                                                       0.683                                  7359.73                                       22.437                                                                          0.657                                   10428.44
  N0                  236    64.7/45.7/40.3                                                                      Reference                                                                                                     47.3/24.5/12.4                                        Reference                                                                
  N1                  194    51.4/35.6/22.8                                                                 1.406(1.048--1.887)                                                                                                38.8/19.2/11.2                                   1.134(0.901--1.439)                                                           
  N2                  653    41.5/34.1/26.5                                                                 1.926(1.523--2.435)                                                                                                 29.8/19.0/9.6                                   1.515(1.266--1.812)                                                           
  N3                  69     23.0/23.0/23.0                                                                 2.869(1.984--4.148)                                                                                                15.8/15.8/10.6                                   1.954(1.422--2.683)                                                           
  R classification                                                 61.697                                                                                       0.686                                  7352.23                                       49.499                                                                          0.661                                   10417.85
  R0                  236    64.7/45.7/40.3                                                                      Reference                                                                                                     47.3/24.5/12.4                                        Reference                                                                
  R1∶0--0.05          177    55.6/45.4/41.3                                                                 1.256(0.930--1.698)                                                                                                43.1/24.7/18.1                                   1.072(0.850--1.352)                                                           
  R2∶0.05--0.30       458    43.6/33.3/22.5                                                                 1.922(1.507--2.452)                                                                                                 31.6/20.7/8.1                                   1.470(1.218--1.775)                                                           
  R3: \>0.30          281    30.7/25.8/16.9                                                                 2.497(1.882--3.314)                                                                                                 21.3/11.0/6.4                                   1.952(1.556--2.448)                                                           

The *P* value for Log-rank χ^2^ tests of cause specific survival was less than 0.001.

Being calculated using the multivariates Cox regression model for cause specific survival with either N classification or R classification and variates listed at [Table 4](#pone-0056613-t004){ref-type="table"} as covariates.

The *P* value for Log-rank χ^2^ tests of overall survival was less than 0.001.

Being calculated using the multivariates Cox regression model for overall survival with N classification or R classification and variates listed at [Table 4](#pone-0056613-t004){ref-type="table"} as covariates.

R Classification as an Index for Selecting High Risk Patients for Postoperative Radiotherapy {#s3d}
--------------------------------------------------------------------------------------------

To analysis the role of the R classification in the management of hypopharyngeal cancer, the cases with (n = 776) and without (n = 292) postoperative radiotherapy according to the Radiation Sequence with Surgery recorded in SEER database were used for further study. Surgery and postoperative radiotherapy improved the CSS for N2 and N3 cases, whereas increased OS was only observed in N2 patients ([Table 6](#pone-0056613-t006){ref-type="table"}). In the case of the R classification, an improvement in both CSS and OS was found for R2 and R3 patients who had received postoperative radiotherapy. To select high risk patients for postoperative radiotherapy, we defined the patients with a N2/N3 classification (n = 669/1068, 62.6%) and R2/R3 classification (n = 682/1068, 63.9%) as the N2-3/R2-3 group (n = 763/1068, 71.4%), a significant improvement (*P*\<0.001) in both the CSS and OS was observed in the N2-3/R2-3 patients who had received postoperative radiotherapy ([Table 6](#pone-0056613-t006){ref-type="table"}; [Fig. 1E and F](#pone-0056613-g001){ref-type="fig"}).

10.1371/journal.pone.0056613.t006

###### The cause-specific survival (CSS) and overall survival (OS) differences between different N classification or R classification patients with and without postoperative radiotherapy (Rx).

![](pone.0056613.t006){#pone-0056613-t006-6}

  Patients' variables    No.   5/10-y CSS (%)   Log-rank χ^2^ [†](#nt109){ref-type="table-fn"}   *P* value   5/10-y OS(%)   Log-rank χ^2^ [†](#nt109){ref-type="table-fn"}   *P* value
  --------------------- ----- ---------------- ------------------------------------------------ ----------- -------------- ------------------------------------------------ -----------
  N classification                                                                                                                                                          
  N0 & Rx --             66      60.1/31.7                          3.507                          0.061      45.5/17.2                         3.139                          0.076
  N0 & Rx +              156     66.7/50.2                                                                    48.3/27.2                                                     
  N1 & Rx --             72      51.5/34.1                          1.360                          0.243      33.9/21.0                         1.567                          0.211
  N1 & Rx +              105     53.9/37.5                                                                    42.6/17.9                                                     
  N2 & Rx --             129     28.6/28.6                          24.185                        \<0.001     18.4/11.7                         33.221                        \<0.001
  N2 & Rx +              476     45.7/36.4                                                                    33.3/21.0                                                     
  N3 & Rx --             25      18.4/18.4                          5.591                          0.018      17.6/17.6                         2.602                          0.107
  N3 & Rx +              39      28.3/28.3                                                                    15.5/15.5                                                     
  R classification                                                                                                                                                          
  R0 & Rx --             66      60.1/31.7                          0.984                          0.061      45.5/17.2                         3.139                          0.076
  R0 & Rx +              156     66.7/50.2                                                                    48.3/27.2                                                     
  R1 & Rx --             34      64.0/64.0                          13.402                         0.321      50.9/42.0                         1.037                          0.308
  R1 & Rx +              130     53.5/40.8                                                                    40.8/19.3                                                     
  R2 & Rx --             68      27.4/27.4                          8.842                         \<0.001     13.7/11.8                         23.053                        \<0.001
  R2 & Rx +              350     47.9/35.8                                                                    35.4/22.9                                                     
  R3 & Rx --             124     29.2/17.2                          17.632                         0.003       20.4/7.9                         7.398                          0.007
  R3 & Rx +              140     32.4/32.4                                                                    22.3/12.7                                                     
  N+R classification                                                                                                                                                        
  Other & Rx --          87      60.1/37.8                          1.068                          0.301      46.4/22.0                         0.547                          0.459
  Other & Rx +           218     61.7/45.1                                                                    45.9/22.7                                                     
  N2-3/R2-3 & Rx --      205     31.9/25.4                          30.584                        \<0.001     20.4/12.4                         37.565                        \<0.001
  N2-3/R2-3 & Rx +       558     45.7/36.5                                                                    33.6/21.1                                                     

For Log-rank χ^2^ test, postoperative radiotherapy (Rx) was defined as factor, the individual R, N and N+R classification were defined as Stratum.

Discussion {#s4}
==========

The hypopharyngeal cancer cases with lymph node metastasis were staged as III/IV according to the AJCC TNM staging system. Approximately 70 to 85% of the patients reported in larger series were diagnosed as having stage III or IV disease at presentation. [@pone.0056613-Pfister1] The management of stages III/IV hypopharyngeal cancer has been relatively unsatisfactory owing to local recurrence and distant metastasis. Optimal therapy has remained a matter of debate, especially with regard to treatment intensity and sequencing. [@pone.0056613-Takes1] Although treatment strategies of cancer advance tremendously, no significant survival improvements were observed in pN+ hypopharyngeal cancer patients diagnosed at different periods as shown in current results, which was also observed for laryngeal cancer and supposed to be caused by inappropriate patients selecting and lack of better index for guiding postoperative therapy. [@pone.0056613-Glynn1], [@pone.0056613-Hoffman1], [@pone.0056613-Chen1] It is plausible that selecting high risk patients is important in the choice of optimal treatment strategies. Current study clearly identified that the LNR is an important prognostic factor for CSS in hypopharyngeal cancer patients with lymph node metastasis. As compared with the N classification, the R classification using the cutoff points 0.05/0.30 showed better predictive ability for CSS and OS, with a lower AIC value and a higher C-index value. The survival curves for R1, R2 and R3 patients were clearly separate even after a 15-year follow-up period, whereas intersection of the survival curves for N 1--3 patients was found after a 10-year follow-up period. The similar survival estimates for R1 and R0 patients further confirmed the role of LNR in stratifying patients (a lower LNR to select lower risk patients).

Over the past three decades, more attention has been paid to the identification of factors that might help the surgeon to assess the precise risk of failure in individual patients. [@pone.0056613-The1], [@pone.0056613-Bernier2] The best predictive index should be easily assessed and dependent on the target measured. For example in primary radiotherapy, volume of the primary tumor may be a predictive factor. [@pone.0056613-Bisdas1], [@pone.0056613-Mendenhall1] For surgical approaches to organ preservation, anatomic sub-localization and extension of the primary tumor are more relevant factors. In the case of postoperative radiotherapy for hypopharyngeal cancer, adverse features were defined as extracapsular nodal spread, positive margins, pT3 or pT4 primary tumor, N2 or N3 nodal disease, selected pT1-T2, N0-N1, perineural invasion and vascular embolism according to the NCCN guidelines. [@pone.0056613-Pfister1] When the CSS and OS of individual R classification patients, with or without postoperative radiotherapy, were compared in the current study, survival benefits were observed for R2 and R3 patients. Combining the N and R classifications together can also select more high risk patients for postoperative radiotherapy than using the N classification alone (62.6% vs. 71.4%). All these results support the fact that R2 and R3 should be defined as adverse features for the postoperative management of hypopharyngeal cancer. Because information regarding the details of radiotherapy (the radiation techniques, dose delivered and fractions, and use of concurrent chemotherapy, etc) and pathological reports (margin status, extracapsular extension, perineural invasion and vascular embolism, etc) are not available in the SEER database, the definitive role of the R classification in postoperative staging and selecting high risk patients for postoperative concurrent chemoradiotherapy could not be discussed in the current study, and is deserving of further research.

Although we have adjusted for all available patient and tumor characteristics in our analysis, as with all SEER based studies, our study was limited by the information available in the database. The SEER database is dependent on the individual physician reporting on the classification of the patient, tumor and treatment characteristics. In this way, it is representative of national patterns of cancer care and has a large population base; however, it is also subject to inconsistencies. Although the number of lymph nodes examined and the number of positive nodes is information that can easily be reported with accuracy, there are still cases that were rejected for inclusion in the current study because of disconcordant information with regard to the N classification and the number of lymph node metastases. The quality of neck dissection achieved by the surgeon, and the quantity of lymph nodes harvested and examined by the pathologist will substantially change the LNR and the results. On the other hand, patients who have a lower number of lymph nodes resected (a relatively lower quality of operation), which may cause inflation of the LNR and a higher R classification, will be assessed as a high risk group. The LNR is an index not only of disease burden but also of surgical standards. This is the reason why the current study, together with studies on cancer from other sites, showed that the LNR improved the predictive ability of survival relative to the N classification. [@pone.0056613-Wang1], [@pone.0056613-Ceelen1], [@pone.0056613-Wang2].

In conclusion, our analysis of the SEER database revealed a significant association between the LNR and survival of hypopharyngeal cancer patients. Using the cutoff points 0.05/0.30, the hypopharyngeal cancer patients with lymph node metastasis were classified into R1, R2 and R3 risk groups. The R classification can be used together with the N classification to select high-risk patients for postoperative treatment. However, more and prospective studies were still needed to confirm the prognostic role of LNR for hypophayryngeal cancer and more clinical evidence should be obtained.

The authors would like to thank SEER for open access to the database and Dr. Minghui Wang from School of Biosciences, The University of Birmingham, UK for his critical discussion of statistical methods.

[^1]: **Competing Interests:**The authors have declared that no competing interests exist.

[^2]: Conceived and designed the experiments: YLW SHF GPZ QHJ. Performed the experiments: YLW SHF JZ GPZ DSL YW YXZ GHS QHJ. Analyzed the data: YLW SHF JZ GPZ DSL YW YXZ GHS QHJ. Contributed reagents/materials/analysis tools: YLW SHF JZ GPZ DSL YW YXZ GHS QHJ. Wrote the paper: YLW SHF JZ GPZ DSL YW YXZ GHS QHJ.
